CAS: 2109-73-1; N-[4-[(2-Methylpropan-2-yl)Oxy]Phenyl]Acetamide

上下游产品

CAS号507-19-7 溴代叔丁烷 | CAS号103-90-2 对乙酰氨基苯酚 | CAS号2109-72-0 1-叔丁氧基-4-硝基苯 | CAS号350-46-9 对氟硝基苯 | CAS号57120-36-2 4-叔丁氧基苯胺

📜4-叔丁氧基苯胺 反应生成4-丁氧基乙酰胺
参考文献:合成哌啶系列.第二部分 哌啶醚及相关化合物的制备
标题:合成哌啶系列.第二部分 哌啶醚及相关化合物的制备
摘要:
Doi:10.1039/jr9540001795

专利信息

专利号:US-2024287041-A1
优先权日:2021-05-20
标题 :Methods of synthesis of heteroaryl derivatives of triazolyl acrylamides and crystalline forms
发明人：BALOGLU ERKAN; AUSTAD BRIAN C; ROE DAVID G; KEDUC ANDREW; GOTTSCHLING STEPHEN EDMUND; HECKER EVAN
权利人:KARYOPHARM THERAPEUTICS INC
摘要:The present invention relates to a method of preparing a compound represented by structural formula (VII), comprising reacting a compound represented by structural formula (II), with a compound represented by structural formula (III), in a solvent, in the presence of a Pd catalyst and one or more inorganic bases under conditions suitable to prepare a compound represented by structural formula (VII): The values and example values of the variables in structural formulas (VII), (II), and (III) are defined herein. The present invention also relates to crystalline Forms I and II of the compound represented by Structural Formula (VII), the use of the crystalline Forms in treating disease or disorders associated with CRM1 and method of preparing the crystalline Forms.

专利号:US-2008214827-A1
优先权日:2004-02-03
标 题:Synthesis of Cyanoimino-Benzoimidazoles
发明人：GOEHRING R RICHARD; WHITEHEAD JOHN; SHAO BIN
权利人:EURO CELTIQUE SA
摘要:Disclosed in certain embodiments is a process for synthesizing a compound of formula (V) and salts thereof.

专利号:AU-2022276509-A1
优先权日:2021-05-20
标题:Methods of synthesis of heteroaryl derivatives of triazolyl acrylamides and crystalline forms

专利号:US-9994558-B2
优先权日:2013-09-20
标题 :Multicyclic compounds and methods of using same
发明人：BALOGLU ERKAN; SHACHAM SHARON; SENAPEDIS WILLIAM; MCCAULEY DILARA; LANDESMAN YOSEF; GOLAN GALI; KALID ORI; SHECHTER SHARON
权利人:KARYOPHARM THERAPEUTICS INC
摘要:The invention generally relates to compounds represented by Structural Formula I: or a pharmaceutically acceptable salt thereof, wherein the variables are as defined and described herein. The invention also includes the synthesis and use of a compound of structural formula I, or a pharmaceutically acceptable salt or composition thereof, e.g., in treatment of cancer (e.g., mantle cell lymphoma), and other diseases and disorders (e.g., PAK-mediated, for example, PAK4-mediated, diseases and disorders).

专利号:WO-2022246227-A1
优先权日:2021-05-20
标 题:Methods of synthesis of heteroaryl derivatives of triazolyl acrylamides and crystalline forms

专利号:WO-9943814-A1
优先权日:1998-02-27
标 题 :Therapeutic blockade of icer synthesis to prevent icer-mediated inhibition of immune cell activity
发明人：COHEN PETER A; BODOR JOSEF; WENG DAVID E; KOSKI GARY K; CZERNIECKI BRIAN J; BODOROVA JANA
权利人:US HEALTH; COHEN PETER A; BODOR JOSEF; WENG DAVID E; KOSKI GARY K; CZERNIECKI BRIAN J; BODOROVA JANA
摘要:The present invention relates to reagents and methods for modulating immune cell activity using agents which regulate the activity of ICER.